N8G-17304-59103 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2022-02-21
Registered in v-safe
2022-02-21
Dose 1 — Pfizer-BioNTech
2022-02-21
Health check-in — day 0, dose 1
Feeling: Good · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2022-02-22
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2022-02-24
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain, Itching · Muscle or body aches

Adult check-in
2022-02-25
Survey response — days 1–6 daily, dose 1
MedDRA: Injection site pain — Feeling: Good · Site: Pain

Free text: Soreness and tenderness at the injection site

MedDRA releases: 2024-11 · check-in free text available
2022-02-26
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2022-02-28
Health check-in — day 7, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2022-03-07
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2022-03-14
Health check-in — day 21, dose 1
Feeling: Good

Adult check-in
2022-03-15
Dose 2 — Pfizer-BioNTech
2022-03-21
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · Muscle or body aches

Adult check-in
2022-03-23
Health check-in — day 7, dose 2
Feeling: Good · Site: Pain · Joint pains · Be unable to do your normal daily activities

Adult check-in
2022-03-31
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2022-04-07
Health check-in — day 21, dose 2
Feeling: Fair

Adult check-in
2022-04-12
Survey response — day 28, dose 2
MedDRA: Muscular weakness, Myalgia — Feeling: Fair · Be unable to do your normal daily activities

Free text: Muscle pain and weakness in arms.

MedDRA releases: 2024-11 · check-in free text available
2022-04-19
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2022-06-15
Survey response — 3 months, dose 2
MedDRA: Mobility decreased, Myalgia, Pain — Feeling: Good · Be unable to do your normal daily activities

Free text: Limited arm movement and muscle ache with movement

MedDRA releases: 2024-11 · check-in free text available
2022-09-13
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2022-02-21	Pfizer-BioNTech	No
2	2022-03-15	Pfizer-BioNTech	No

Free text

Release 11 — days 1–6 daily, dose 1

2022-02-25

Systemic reaction (other): Soreness and tenderness at the injection site

Release 11 — day 28, dose 2

2022-04-12

Symptoms: Muscle pain and weakness in arms.

Release 12 — 3 months, dose 2

2022-06-15

Symptoms: Limited arm movement and muscle ache with movement

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Mobility decreased	·	·	✓
SD	Muscular weakness	·	·	✓
SD	Myalgia	·	·	✓
SD	Pain	·	·	✓
SRO	Injection site pain	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release